Publication | Open Access

Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease

Dual Phosphodiesterase 5Medicinal ChemistryNeurodegenerative DiseasesAlzheimer's DiseaseMedicineDementiaTreatment EvaluationHistone Deacetylase 6Neurochemical BiomarkersNeurologyBrain PathologyVivo TestingPharmacologyTreatmentDrug Discovery